Jean-François Riou1, Dennis Gomez, Thibault Lemarteleur
1Institut fédératif de recherche 53, UFR de Pharmacie, Université de Reims-Champagne-Ardenne, 51, rue Cognacq-Jay, 51096 Reims. jf.riou@univ-reims.fr
Guanine-quadruplex ligands show promise in cancer therapy by inhibiting telomerase activity. Further research is needed to confirm the intracellular presence of G-quadruplex structures for targeted drug development.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Context:
Purpose:
Summary:
Impact: